SECsense Logo

NeuroOne Medical Technologies 8-K Report: Key Updates & Insights

$NMTC
Form 8-K
Filed on: 2024-12-17
Source
NeuroOne Medical Technologies 8-K Report: Key Updates & Insights

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: NeuroOne Medical Technologies Corporation
  • CIK Number: 0001500198
  • SEC File Number: 001-40439
  • EIN: 27-0863354
  • Address: 7599 Anagram Dr., Eden Prairie, MN 55344
  • Phone Number: 952-426-1383
  1. Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: December 17, 2024
  1. Stock Information:
  • Security: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: NMTC
  • Exchange: NASDAQ
  1. Context of Financial Reporting:
  • Reporting Period: The report covers the date of December 17, 2024, indicating it may reflect a specific event or update as required by the SEC for Form 8-K.
  1. Unit of Measurement:
  • Currency: USD (United States Dollar)
  • Shares: The report involves metrics that include both monetary values and share counts.
  1. Miscellaneous:
  • The document uses XBRL (eXtensible Business Reporting Language) for structured financial reporting, which allows for easier data extraction and analysis.

Insights:

  • The filing of an 8-K suggests that NeuroOne Medical Technologies Corporation has experienced a significant event that necessitates immediate disclosure. This could be related to changes in management, financial updates, or other material events.
  • The company trades on NASDAQ under the ticker NMTC, indicating its status as a publicly traded entity, which may be of interest to investors and analysts monitoring stock performance.
  • The low par value of the common stock ($0.001) may suggest a strategy of maintaining a high number of shares outstanding, which is common for companies aiming to keep share prices more accessible.

This information is crucial for stakeholders, including investors, analysts, and regulatory bodies, for understanding the company's current status and potential future developments.